Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 165 publications
Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside.
Journal: Circulation research
Published: June 04, 2026
ApoB: The intracellular protein detection dilemma in lipoprotein biology.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: June 22, 2025
Corrigendum to "Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA" [Atherosclerosis (2025) 403 119114].
Journal: Atherosclerosis
Published: May 02, 2025
Breaking up prolonged sedentary behavior to improve cardiometabolic health (BREAK2): protocol for a dose-finding adaptive randomization trial.
Journal: BMC public health
Published: December 30, 2024
Differential effects of volanesorsen on apoC-III, triglycerides, and pancreatitis in familial chylomicronemia syndrome diagnosed by genetic or nongenetic criteria.
Journal: Journal of clinical lipidology
Published: November 18, 2024
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?
Journal: Pharmacology & therapeutics
Published: November 16, 2024
Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA.
Journal: Atherosclerosis
Published: August 22, 2024
Single Dose of Phosphatidylinositol 3-Kinase Inhibitor Alpelisib Induces Insulin Resistance in Healthy Adults: A Randomized Feasibility Study.
Journal: Diabetes
Published: May 13, 2024
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 02, 2024
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
Journal: The New England journal of medicine
Published: April 08, 2024
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism.
Journal: Current opinion in lipidology
Published: March 11, 2024
Last Updated: 09/26/2026